Induction of senescence by adenosine suppressing the growth of lung cancer cells

Biochemical and Biophysical Research Communications

Volumn 440, Issue 1, 2013, Pages 62-67

  Yang, Dongqin ^a   Song, Junyao ^b   Wu, Lijun ^a   Ma, Yunfang ^a   Song, Chunhua ^c   Dovat, Sinisa ^c   Nishizaki, Tomoyuki ^d   Liu, Jie ^a  

^a FUDAN UNIVERSITY   (China)

^b Massachusetts Institute of Technology Cambridge   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

A549 cell; Adenosine; Cellular senescence; DNA damage

Indexed keywords

ADENOSINE; ADENOSINE A3 RECEPTOR; BETA GALACTOSIDASE; BRCA1 PROTEIN; CHECKPOINT KINASE 2; HISTONE H2AX; PROTEIN P21; PROTEIN P53;

ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL AGING; COMPARATIVE STUDY; CONTROLLED STUDY; DNA DAMAGE; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

A549 CELL; ADENOSINE; CELLULAR SENESCENCE; DNA DAMAGE;

ADENOSINE; ANIMALS; ANTINEOPLASTIC AGENTS; CELL AGING; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84885369931     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.09.030     Document Type: Article

References (18)

1. Yang D., Yaguchi T., Yamamoto H., Nishizaki T. Intracellularly transported adenosine induces apoptosis in HuH-7 human hepatoma cells by downregulating c-FLIP expression causing caspase-3/-8 activation. Biochem. Pharmacol. 2007, 73:1665-1675.
2. Saitoh M., Nagai K., Nakagawa K., Yamamura T., Yamamoto S., Nishizaki T. Adenosine induces apoptosis in the human gastric cancer cells via an intrinsic pathway relevant to activation of AMP-activated protein kinase. Biochem. Pharmacol. 2004, 67:2005-2011.
3. Yang D., Yaguchi T., Lim C.-R., Ishizawa Y., Nakano T., Nishizaki T. Tuning of apoptosis-mediator gene transcription in HepG2 human hepatoma cells through an adenosine signal. Cancer Lett. 2010, 291:225-229.
4. Linskens M.H., Feng J., Andrews W.H., Enlow B.E., Saati S.M., Tonkin L.A., Funk W.D., Villeponteau B. Cataloging altered gene expression in young and senescent cells using enhanced differential display. Nucleic Acids Res. 1995, 23:3244-3251.
5. Shelton D.N., Chang E., Whittier P.S., Choi D., Funk W.D. Microarray analysis of replicative senescence. Curr. Biol. 1999, 9:939-945.
6. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
7. Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997, 88:593-602.
8. te Poele R.H., Okorokov A.L., Jardine L., Cummings J., Joel S.P. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res. 2002, 62:1876-1883.
9. Shay J.W., Roninson I.B. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 2004, 23:2919-2933.
10. Smith J.R., Pereira-Smith O.M. Replicative senescence: implications for in vivo aging and tumor suppression. Science 1996, 273:63-67.
11. Rebbaa A. Targeting senescence pathways to reverse drug resistance in cancer. Cancer Lett. 2005, 219:1-13.
12. Hirao A. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 2000, 287:1824-1827.
13. Schmitt C.A., Fridman J.S., Yang M., Lee S., Baranov E., Hoffman R.M., Lowe S.W. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 2002, 109:335-346.
14. Campisi J., d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 2007, 8:729-740.
15. Yang D., Li L., Liu H., Wu L., Luo Z., Li H., Zheng S., Gao H., Chu Y., Sun Y., Liu J., Jia L. Induction of autophagy and senescence by knockdown of ROC1 E3 ubiquitin ligase to suppress the growth of liver cancer cells. Cell Death Differ. 2013, 20:235-247.
16. Ross W.E., Bradley M.O. DNA double-stranded breaks in mammalian cells after exposure to intercalating agents. Biochim. Biophys. Acta 1981, 654:129-134.
17. Lau D.H., Lewis A.D., Ehsan M.N., Sikic B.I. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin. Cancer Res. 1991, 51:5181-5187.
18. Banath J.P., Olive P.L. Expression of phosphorylated histone H2AX as a surrogate of cell killing by drugs that create DNA double-strand breaks. Cancer Res. 2003, 63:4347-4350.